• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素敏感性参数对分化型甲状腺癌患者颈部淋巴结转移的预测价值。

The predictive value of thyroid hormone sensitivity parameters for cervical lymph node metastasis in patients with differentiated thyroid cancer.

作者信息

Bi Jingcheng, Yao Tianqi, Yao Yu, Zhu Zhengcai, Lei Qiucheng, Jiao Lianghe, Li Tao

机构信息

Department of General Surgery, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.

Department of Hepatopancreatic Surgery/Organ Transplantation Center, The First People's Hospital of Foshan, Foshan, China.

出版信息

Ann Med. 2025 Dec;57(1):2443564. doi: 10.1080/07853890.2024.2443564. Epub 2024 Dec 27.

DOI:10.1080/07853890.2024.2443564
PMID:39731362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11703106/
Abstract

OBJECTIVE

To comprehensively investigate the predictive value of thyroid hormone sensitivity parameters for cervical lymph node metastasis in patients diagnosed with differentiated thyroid cancer (DTC) undergoing total thyroidectomy and neck lymph node dissection.

METHODS

A retrospective cohort study was conducted involving patients diagnosed with DTC and evaluated for cervical lymph node metastasis. Relevant demographic, tumour, lymph node and thyroid hormone sensitivity parameter data were extracted from medical records and laboratory reports. Thyroid hormone sensitivity parameters including thyroxine (T4), triiodothyronine (T3), thyroid-stimulating hormone (TSH), thyroglobulin (Tg), thyroglobulin antibodies (TgAbs), thyroid peroxidase antibody, thyroid hormone receptor α and TSH receptor antibody were assessed. Statistical analyses including descriptive statistics, comparative analysis, Pearson's correlation analysis, logistic regression analysis, receiver operating characteristic (ROC) analysis and construction of a multivariable prediction model based on machine learning using the xgbTree method were employed to evaluate the associations and predictive value of thyroid hormone sensitivity parameters for cervical lymph node metastasis.

RESULTS

The study revealed significant associations between several thyroid hormone sensitivity parameters and cervical lymph node metastasis in patients with DTC. Specifically, higher levels of T4, T3, Tg, TgAbs and TSH receptor antibody were associated with lymph node metastasis. Pearson's correlation analysis, logistic regression analysis and ROC analysis further underscored the predictive performance of these parameters, with strong overall discriminative abilities. The machine learning-based prediction model demonstrated promising performance with a high area under the curve (AUC) of 0.979.

CONCLUSIONS

The findings provide compelling evidence for the predictive value of thyroid hormone sensitivity parameters, particularly T3, T4, Tg, TgAbs and TSH receptor antibody, in identifying and evaluating the likelihood of cervical lymph node metastasis in patients with DTC. These parameters hold potential implications for risk stratification, clinical decision-making and personalized management strategies, contributing to improved outcomes for patients at risk of lymph node metastasis.

摘要

目的

全面研究甲状腺激素敏感性参数对接受全甲状腺切除术和颈部淋巴结清扫术的分化型甲状腺癌(DTC)患者颈部淋巴结转移的预测价值。

方法

进行一项回顾性队列研究,纳入被诊断为DTC并接受颈部淋巴结转移评估的患者。从病历和实验室报告中提取相关的人口统计学、肿瘤、淋巴结及甲状腺激素敏感性参数数据。评估甲状腺激素敏感性参数,包括甲状腺素(T4)、三碘甲状腺原氨酸(T3)、促甲状腺激素(TSH)、甲状腺球蛋白(Tg)、甲状腺球蛋白抗体(TgAbs)、甲状腺过氧化物酶抗体、甲状腺激素受体α和TSH受体抗体。采用包括描述性统计、比较分析、Pearson相关分析、逻辑回归分析、受试者工作特征(ROC)分析以及使用xgbTree方法基于机器学习构建多变量预测模型等统计分析方法,来评估甲状腺激素敏感性参数与颈部淋巴结转移的关联及预测价值。

结果

该研究揭示了DTC患者中几个甲状腺激素敏感性参数与颈部淋巴结转移之间存在显著关联。具体而言,T4、T3、Tg、TgAbs和TSH受体抗体水平较高与淋巴结转移相关。Pearson相关分析、逻辑回归分析和ROC分析进一步强调了这些参数的预测性能,具有较强的总体判别能力。基于机器学习的预测模型表现出良好的性能,曲线下面积(AUC)高达0.979。

结论

这些发现为甲状腺激素敏感性参数,特别是T3、T4、Tg、TgAbs和TSH受体抗体,在识别和评估DTC患者颈部淋巴结转移可能性方面的预测价值提供了有力证据。这些参数对风险分层、临床决策和个性化管理策略具有潜在意义,有助于改善有淋巴结转移风险患者的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/dc302ea4b5a4/IANN_A_2443564_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/e0754afab970/IANN_A_2443564_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/c539e74a3e13/IANN_A_2443564_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/7e26720dc245/IANN_A_2443564_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/dc302ea4b5a4/IANN_A_2443564_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/e0754afab970/IANN_A_2443564_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/c539e74a3e13/IANN_A_2443564_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/7e26720dc245/IANN_A_2443564_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeb4/11703106/dc302ea4b5a4/IANN_A_2443564_F0004_C.jpg

相似文献

1
The predictive value of thyroid hormone sensitivity parameters for cervical lymph node metastasis in patients with differentiated thyroid cancer.甲状腺激素敏感性参数对分化型甲状腺癌患者颈部淋巴结转移的预测价值。
Ann Med. 2025 Dec;57(1):2443564. doi: 10.1080/07853890.2024.2443564. Epub 2024 Dec 27.
2
Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.全甲状腺切除术后连续测定血清甲状腺球蛋白对分化型甲状腺癌的预后价值
J Endocrinol Invest. 2002 Feb;25(2):110-5. doi: 10.1007/BF03343973.
3
Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.甲状腺乳头状癌颈淋巴结转移预测模型。
Cancer Control. 2024 Jan-Dec;31:10732748241295347. doi: 10.1177/10732748241295347.
4
Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.甲状腺球蛋白检测联合细针穿刺活检对分化型甲状腺癌病史患者淋巴结转移的诊断价值
Asian Pac J Cancer Prev. 2014;15(24):10905-9. doi: 10.7314/apjcp.2014.15.24.10905.
5
Evaluation of the value of combined thyroid function-related indexes in the prognosis prediction of patients with differentiated thyroid cancer.评估甲状腺功能相关指标联合检测在分化型甲状腺癌患者预后预测中的价值。
Medicine (Baltimore). 2024 Jul 5;103(27):e38787. doi: 10.1097/MD.0000000000038787.
6
Diagnostic value of microRNA-129-5p and TSH combination for papillary thyroid cancer with cervical lymph node metastasis.微小RNA-129-5p与促甲状腺激素联合检测对伴颈部淋巴结转移的甲状腺乳头状癌的诊断价值
Int J Biol Markers. 2025 Mar;40(1):46-54. doi: 10.1177/03936155241303763. Epub 2025 Mar 2.
7
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中,抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时,诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.
8
Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.甲状腺癌患者消融前刺激甲状腺球蛋白和甲状腺球蛋白/促甲状腺激素比值的预测价值。
Clin Nucl Med. 2011 Dec;36(12):1102-5. doi: 10.1097/RLU.0b013e3182291c65.
9
Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer.分化型甲状腺癌甲状腺部分切除术后残余甲状腺组织及颈部淋巴结恶性肿瘤的发生率及预测因素
Surgery. 2002 Apr;131(4):443-9. doi: 10.1067/msy.2002.122377.
10
PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.消融前甲状腺球蛋白及甲状腺球蛋白与促甲状腺激素比值可能与分化型甲状腺癌患儿的肺转移有关。
Endocr Pract. 2016 Nov;22(11):1259-1266. doi: 10.4158/EP161360.OR. Epub 2016 Aug 2.

本文引用的文献

1
Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer.促甲状腺激素受体(TSHR)作为分化型甲状腺癌成像的靶点。
Surgery. 2024 Jan;175(1):199-206. doi: 10.1016/j.surg.2023.05.045. Epub 2023 Oct 31.
2
Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases.正常甲状腺分化型甲状腺癌病例中血清甲状腺激素和甲状腺球蛋白比值诊断特征的测定
Sisli Etfal Hastan Tip Bul. 2023 Jun 20;57(2):257-262. doi: 10.14744/SEMB.2023.77012. eCollection 2023.
3
Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy.
分化型甲状腺癌:关注术后甲状腺激素替代和促甲状腺素抑制治疗。
Endocrine. 2024 Feb;83(2):251-258. doi: 10.1007/s12020-023-03548-8. Epub 2023 Oct 12.
4
Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.甲状腺髓样癌中央区或侧颈部淋巴结转移的危险因素:系统评价和荟萃分析。
Eur Arch Otorhinolaryngol. 2024 Feb;281(2):547-561. doi: 10.1007/s00405-023-08249-6. Epub 2023 Oct 6.
5
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.促胃液素抑制素受体 2 和促甲状腺激素受体在嗜酸细胞性甲状腺肿瘤中的表达:对预后和治疗的影响。
Mod Pathol. 2023 Dec;36(12):100332. doi: 10.1016/j.modpat.2023.100332. Epub 2023 Sep 15.
6
Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma.促甲状腺激素抑制治疗与分化型甲状腺癌中2型脱碘酶基因多态性的关联。
Endokrynol Pol. 2023 Jul 11. doi: 10.5603/EP.a2023.0043.
7
Thyroid cancer.甲状腺癌。
Lancet. 2023 May 6;401(10387):1531-1544. doi: 10.1016/S0140-6736(23)00020-X. Epub 2023 Apr 3.
8
Active Surveillance of Differentiated Thyroid Cancer Metastatic Cervical Lymph Nodes: A Retrospective Single-Center Cohort Study.分化型甲状腺癌转移性颈部淋巴结的主动监测:一项回顾性单中心队列研究
Thyroid. 2023 Mar;33(3):312-320. doi: 10.1089/thy.2022.0542. Epub 2023 Feb 15.
9
Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis.低危分化型甲状腺癌的当前争议:在过度诊断时代减少过度治疗。
J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280. doi: 10.1210/clinem/dgac646.
10
Thyroidectomy for the Management of Differentiated Thyroid Carcinoma and their Outcome on Early Postoperative Complications: A 6-year Single-Centre Retrospective Study.甲状腺切除术治疗分化型甲状腺癌及其术后早期并发症的结果:一项 6 年单中心回顾性研究。
Chirurgia (Bucur). 2022 Oct;117(5):556-562. doi: 10.21614/chirurgia.2736.